Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
101 hedge funds and large institutions have $91.9M invested in Avid Bioservices, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 16 closing their positions.
1,675% more call options, than puts
Call options by funds: $142K | Put options by funds: $8K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
0% more funds holding
Funds holding: 101 → 101 (0)
20% less capital invested
Capital invested by funds: $114M → $91.9M (-$22.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Legato Capital Management
San Francisco,
California
|
+$1.24M |
| 2 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$1.02M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$714K |
| 4 |
Renaissance Technologies
New York
|
+$646K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$629K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BP
Bandera Partners
New York
|
-$2.34M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$747K |
| 3 |
Millennium Management
New York
|
-$624K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$567K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$389K |
CDMO Hedge Fund Activity: Q4 2018 in Review
101 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2018, worth a combined $91.9M — down 20% from $114M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CDMO positions and 16 closed out — a net gain of 1 holder — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Legato Capital Management, opening a new position worth an estimated $1.24M. The largest seller was Bandera Partners, cutting an estimated $2.34M.
- 101 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $91.9M of Avid Bioservices, Inc. Common Stock stock for Q4 2018, down 20% quarter-over-quarter.
- 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2018 and 16 closed out, a net change of +1 holder.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2018 was Legato Capital Management, an estimated $1.24M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2018 was Bandera Partners, an estimated $2.34M sold.
Based on aggregated 13F filings for Q4 2018.